PUB ALERT: Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42202246/

DUE WEDNESDAY. Have communications experience and want to learn more about RTOG? We are now accepting applications for our July 2026- July 2027 RTOG Foundation Communications Interns. More details: https://ow.ly/586M50YIRRc Applications due JUNE 10TH

PUB ALERT: Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant Meningiomas - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42143623/

June is National Cancer Survivors Month. Our patients are the focal point of everything we do as we strive to grow the number of cancer survivors through research.

NEXT WEEK!! REGISTER for our NRG-GU015 "ARCHER" site webinar discussing the study assessments for the trial studying shorter duration RT for patients receiving chemotherapy for bladder cancer. This webinar will be June 9th at 1:00PM ET. Register at http://bit.ly/NRG-ARCHER-RT

Thank you to all who attended our #RadOnc reception at #ASCO26 and a special thank you to our sponsor and co-host Novocure for making this possible. https://conta.cc/3RWcjRv

Attending #NRG2026 in Denver this July? We'll see you there! Don't forget to register before the deadline on June 23rd to avoid paying late registration fees. More information and how to register is available at https://www.nrgoncology.org/meetings/2026-summer-mtg/

Have communications experience and want to learn more about RTOG? We are now accepting applications for our July 2026- July 2027 RTOG Foundation Communications Interns. More details: https://ow.ly/8MN650YIRMt Applications due JUNE 10TH

This a reminder that our office will reopen tomorrow, Tuesday, May 26th. Happy Memorial Day!

Please note the upcoming holiday hours for RTOG Foundation. We will close at 12PM ET on Friday, May 22nd and will reopen on Tuesday, May 26th.

Today is #ClinicalTrialsDay & the theme is #ResearchRising. We are driven by the purpose to improve the lives of cancer patients & ultimately to one day find a cure for all types of cancer. Thank you to all of our partners, researchers & patients for your endless contributions!

For #BladderCancer Awareness Month, NRG highlighted the currently enrolling ARCHER trial assessing adaptive radiotherapy and chemotherapy for muscle invasive bladder cancer: https://ow.ly/QqCf50YYZA9

For #BladderCancer Awareness Month, NRG highlighted the currently enrolling PARRC trial of immunotherapy and radiation therapy for non-muscle invasive bladder cancer: https://ow.ly/vvgy50YYZjh

Have communications experience and want to learn more about RTOG? We are now accepting applications for our July 2026- July 2027 RTOG Foundation Communications Interns. More details: https://ow.ly/8MN650YIRMt Applications due JUNE 10TH

Happy National Nurses Week! We are incredibly thankful for all their hard work and dedication to our research and to those impacted by cancer. Thank you for being on the front lines of patient care! #NursesDay #NursesWeek #ThankaNurse

May kicks off #BrainCancer & #BladderCancer Awareness Month! RTOGF past publications on brain & bladder cancer research can be found on our website https://ow.ly/nhua50YTbjN as well as NRG publications and current trials in this space can be found on https://ow.ly/IQTz50YTbjM#BrainCancer

Are you attending ASCO 2026 this year? We're hosting a reception with Novocure for radiation oncologists on Saturday during ASCO from 4-6PM at Sunda. Register here: https://www.surveymonkey.com/r/RTOGNovocure

It's the last week of #HeadandNeckCancer Awareness Month! We currently have RTOG 3521 open in our head and neck portfolio. Stay tuned throughout the month as we focus on H&N Cancer research through RTOGF. More on our active studies can be found here: https://ow.ly/t6pM50YIS72#HeadandNeckCancer

Have communications experience and want to learn more about RTOG? We are now accepting applications for our July 2026- July 2027 RTOG Foundation Communications Interns. More details: https://ow.ly/8MN650YIRMt Applications due JUNE 10TH

If you are attending the ACR Meeting in Washington, D.C. be sure to stop by the “Therapeutic Radiopharmaceuticals: Where Specialties Combine to Bring Novel Cancer Interventions” session. This session will be held Saturday, May 2nd from 3:00-5:00pm ET in the Cabinet Room at the Washington Hilton.

In case you missed it, we shared a video interview with Dr. Nabil Saba, Principal Investigator of the currently enrolling NRG-HN016 "NEOPOLIS" trial in advanced head and neck cancer. Check it out: https://youtu.be/Q5pkjkB-rK0?si=7twbKqvbQGvTTeIK

In our Spring Newsletter, Dr. Jeff Michalski discusses all things theranostics and its importance in radiation oncology. Read the interview: https://ow.ly/J7Fx50YIRcV

The Spring 2026 RTOG Foundation newsletter is now available! See inside: https://conta.cc/4sgoeq4

Did you know, a great deal of the effort that goes into clinical research is on a volunteer level? We are so thankful for the many patient advocates and researchers that put in the extra work to amplify our research and continue to advance our practices.

April is National Cancer Prevention & Early Detection Month. Early detection saves lives. Prevention matters.

April kicks off #HeadandNeckCancer Awareness Month! We currently have RTOG 3521 open in our head and neck portfolio. Stay tuned throughout the month as we focus on H&N Cancer research through RTOGF. More on our active studies can be found here: https://rtog.org/Clinical-Trials/Foundation-Studies#HeadandNeckCancer

PUB ALERT: Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy with either cisplatin or cetuximab in the NRG/RTOG 1016 randomized controlled trial - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41825810/

Today is #NationalDoctorsDay - we are thankful today and every day for our many physicians who lead the way for RTOG Foundation research.

PUB ALERT: The KRAS-variant and cetuximab in HPV-positive oropharyngeal cancer - results from the NRG/RTOG 1016 trial (Cancer Res Commun.) - PubMed link: https://pubmed.ncbi.nlm.nih.gov/41790036/

March is #KidneyCancer & #ColorectalCancer Awareness Month. RTOG Foundation past publications on kidney & colorectal cancer research can be found on our website https://ow.ly/6yMc50YvgYl as well as on the NRG website https://ow.ly/vr0G50YvgYr

PUB ALERT: Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005 - In JCO - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41529214/

Did you know more information on the recently opened RTOG 3523 trial for progressive intracranial grade 1-3 meningioma is available on our website? Protocol documents are also available behind the login. https://www.rtog.org/Clinical-Trials/Foundation-Studies/3523

Did You Know? There are several ways you can participate in RTOG Foundation as a member site, an industry collaborator, or by enrolling in one of our studies. Read more on our website about how you can partner with RTOG Foundation. Learn more at http://RTOG.org/Partners

March is #KidneyCancer & #ColorectalCancer Awareness Month. RTOG Foundation past pubs on kidney & colorectal cancer research can be found on our website https://rtog.org/Clinical-Trials/Publications as well as on the NRG website https://nrgoncology.org/Clinical-Trials/Publications/Publication-Search

PUB ALERT: Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review - in JNCI - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41629764/

TOMORROW - Register today: Learn more about radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Registration link: https://ow.ly/IX7l50Y0fUI

PUB ALERT: A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41324555/

PUB ALERT: Driving progress in recurrent and metastatic head and neck cancer: the NRG oncology perspective - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41627880/

Learn more about radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Register here: https://ow.ly/IX7l50Y0fUI

Happy International Women and Girls in Science Day! Today we celebrate the brilliant women and girls who are breaking barriers, leading discoveries, and shaping the future through science and research.

TODAY! ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/Roy050XTlTz

PUB ALERT: Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005 - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41063518/

If you are attending the Multidisciplinary H&N Cancer Symposium next week, be sure to stop by the NRG-HN014 Investigators Meeting. in Directors Room B!

Today is #WorldCancerDay - a day focused on the importance of early detection and the need to support and fund research aimed towards a cure. #WorldCancerDay 💜

Today we celebrate our women physicians on the birthday of Dr. Blackwell. We greatly appreciate the contributions and achievements of the women on the frontlines of our clinical research. #NationalWomenPhysiciansDay

ONE WEEK AWAY! ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/8AOp50XTlTb

February is #CancerPreventionMonth - Please be sure to start conversations with your doctor and look into the various measures you can take to help reduce your cancer risk.

We are very interested to learn more about this topic in radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Register here: https://ow.ly/lzBs50Y0fUJ

Did you know more information on the recently opened RTOG 3523 trial for progressive intracranial grade 1-3 meningioma is available on our website? Protocol documents are also available behind the login. https://www.rtog.org/Clinical-Trials/Foundation-Studies/3523

ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/70PC50XTlR8